Prevalence and patterns of left ventricular hypertrophy in patients with predialysis chronic renal failure

Area of Science:

• Cardiology
• Nephrology
• Medical Research

Background:

• Left ventricular hypertrophy (LVH) is a significant risk factor for cardiac mortality.
• Chronic renal failure (CRF) is associated with increased cardiovascular risks.
• Understanding LVH prevalence and patterns in predialysis CRF is crucial for risk stratification.

Purpose of the Study:

• To determine the prevalence and patterns of LVH in patients with predialysis CRF.
• To analyze the relationship between LVH and predisposing factors in this population.

Main Methods:

• Echocardiography was used to measure left ventricular mass index (LVMI) and relative wall thickness (RWT) in 62 predialysis CRF patients (serum creatinine > 2 mg/dl).
• Patients were categorized into four groups based on LVMI and RWT: normal, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy.
• Statistical analyses explored correlations between LVMI and clinical parameters including blood pressure, serum creatinine, creatinine clearance, hemoglobin, and intact parathyroid hormone.

Main Results:

• A high prevalence of LVH (87%) was observed in predialysis CRF patients.
• Concentric hypertrophy was the predominant pattern, identified in 56.5% of patients.
• LVMI showed significant linear correlations with systolic and diastolic blood pressure, serum creatinine, and intact parathyroid hormone.
• Inverse linear correlations were found between LVMI and creatinine clearance and hemoglobin levels.
• LVMI increased with declining renal function.

Conclusions:

• Predialysis CRF is associated with a high prevalence of LVH, primarily concentric hypertrophy.
• Factors including anemia, hypertension, impaired renal function, and elevated parathyroid hormone levels contribute to LVH in CRF patients.
• These findings highlight the need for early detection and management of LVH in CRF to mitigate cardiac risks.